{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:17:27Z","timestamp":1792808247869,"version":"4.5.0"},"reference-count":53,"publisher":"American Association for Cancer Research (AACR)","issue":"7","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"crossref","award":["6651-23"],"award-info":[{"award-number":["6651-23"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002039","name":"CURE Childhood Cancer","doi-asserted-by":"crossref","award":["970166"],"award-info":[{"award-number":["970166"]}],"id":[{"id":"10.13039\/100002039","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001445","name":"Alex's Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"crossref","award":["51102"],"award-info":[{"award-number":["51102"]}],"id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"crossref"}]},{"name":"\ud604\ub300\uc790\ub3d9\ucc28\uadf8\ub8f9 | Hyundai Motor America | Hyundai Hope On Wheels","award":["52214"],"award-info":[{"award-number":["52214"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,17]]},"abstract":"<jats:p>Siglec-15 (Sig15) has been implicated as an immune checkpoint expressed in solid tumor-infiltrating macrophages and is being targeted in clinical trials with mAbs to normalize the tumor immune microenvironment and stimulate antitumor immunity. However, the role of Sig15 in hematologic malignancies remains undefined. Sig15 mRNA and protein expression levels in hematologic malignancies were determined from publicly available databases, cell lines, and primary patient samples. Human B-cell acute lymphoblastic leukemia (B-ALL) cell lines were used to identify signaling pathways involved in the regulation of Sig15 expression. Secreted\/soluble Sig15 and cytokine levels were measured from the plasma of children with leukemia and healthy controls. Knockdown and knockout of Siglec15 in a murine model of B-ALL was used to evaluate the effect of leukemia-derived Sig15 on the immune response to leukemia. We observed pathologic overexpression of Sig15 in a variety of hematologic malignancies, including primary B-ALL samples. This overexpression was driven by NF\u03baB activation, which also increased the surface localization of Sig15. Secreted\/soluble Sig15 was found to circulate at elevated levels in the plasma of children with B-ALL and correlated with an immune-suppressive cytokine milieu. Genetic inhibition of Sig15 in murine B-ALL promoted clearance of the leukemia by the immune system and a marked reversal of the immune-privileged leukemia bone marrow niche, including expanded early effector CD8+ T cells and reduction of immunosuppressive cytokines. Thus, Sig15 is a novel, potent immunosuppressive molecule active in leukemia that may be targeted therapeutically to activate T lymphocytes against leukemia cells.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>We demonstrate that Sig15 is overexpressed in hematologic malignancies driven by NF\u03baB, is required for immune evasion in a mouse model of leukemia, and, for the first time, that it circulates at high levels in the plasma of children with leukemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-23-0056","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T15:43:35Z","timestamp":1687621415000},"page":"1248-1259","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5435-6198","authenticated-orcid":true,"given":"Claire E.","family":"Pillsbury","sequence":"first","affiliation":[{"name":"1Cancer Biology Program, Laney Graduate School, Emory University, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4271-1288","authenticated-orcid":true,"given":"Jodi","family":"Dougan","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5837-7087","authenticated-orcid":true,"given":"Jennifer L.","family":"Rabe","sequence":"additional","affiliation":[{"name":"3Molecular Biology Program, University of Colorado Denver, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5456-4694","authenticated-orcid":true,"given":"Jairo A.","family":"Fonseca","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1518-7053","authenticated-orcid":true,"given":"Chengjing","family":"Zhou","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-0719","authenticated-orcid":true,"given":"Alyssa N.","family":"Evans","sequence":"additional","affiliation":[{"name":"4Winship Cancer Institute, Emory University, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3088-573X","authenticated-orcid":true,"given":"Hasan","family":"Abukharma","sequence":"additional","affiliation":[{"name":"5NextCure, Inc. Beltsville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9471-1537","authenticated-orcid":true,"given":"Ona","family":"Ichoku","sequence":"additional","affiliation":[{"name":"5NextCure, Inc. Beltsville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4581-4975","authenticated-orcid":true,"given":"Gloria","family":"Gonzalez-Flamenco","sequence":"additional","affiliation":[{"name":"6Clinical Laboratory, Children's Healthcare of Atlanta, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-0519","authenticated-orcid":true,"given":"Sunita I.","family":"Park","sequence":"additional","affiliation":[{"name":"6Clinical Laboratory, Children's Healthcare of Atlanta, Atlanta, Georgia."},{"name":"7Department of Pathology, Emory University School of Medicine, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1839-1535","authenticated-orcid":true,"given":"Ahmed","family":"Aljudi","sequence":"additional","affiliation":[{"name":"6Clinical Laboratory, Children's Healthcare of Atlanta, Atlanta, Georgia."},{"name":"7Department of Pathology, Emory University School of Medicine, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7457-9006","authenticated-orcid":true,"given":"Deborah","family":"DeRyckere","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia."},{"name":"4Winship Cancer Institute, Emory University, Atlanta, Georgia."},{"name":"8Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8367-2002","authenticated-orcid":true,"given":"Sharon M.","family":"Castellino","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia."},{"name":"4Winship Cancer Institute, Emory University, Atlanta, Georgia."},{"name":"8Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9295-3065","authenticated-orcid":true,"given":"Sarwish","family":"Rafiq","sequence":"additional","affiliation":[{"name":"4Winship Cancer Institute, Emory University, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9596-4931","authenticated-orcid":true,"given":"Solomon","family":"Langermann","sequence":"additional","affiliation":[{"name":"5NextCure, Inc. Beltsville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4220-1076","authenticated-orcid":true,"given":"Linda N.","family":"Liu","sequence":"additional","affiliation":[{"name":"5NextCure, Inc. Beltsville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5523-554X","authenticated-orcid":true,"given":"Curtis J.","family":"Henry","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia."},{"name":"4Winship Cancer Institute, Emory University, Atlanta, Georgia."},{"name":"8Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8774-0180","authenticated-orcid":true,"given":"Christopher C.","family":"Porter","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia."},{"name":"4Winship Cancer Institute, Emory University, Atlanta, Georgia."},{"name":"8Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"2023071714005159100_bib1","article-title":"SEER cancer statistics review, 1975\u20132018","author":"Howlader"},{"key":"2023071714005159100_bib2","article-title":"Childhood acute lymphoblastic leukemia treatment (PDQ\u00ae): health professional version","author":"PDQ Pediatric Treatment Editorial Board","year":"2021"},{"key":"2023071714005159100_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/PAS.0000000000000982","article-title":"B lymphoblastic leukemia\/lymphoma with burkitt-like morphology and IGH\/MYC rearrangement: report of 3 cases in adult patients","volume":"42","author":"Li","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"2023071714005159100_bib4","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1182\/blood.2019004043","article-title":"How I treat relapsed acute lymphoblastic leukemia in the pediatric population","volume":"136","author":"Hunger","year":"2020","journal-title":"Blood"},{"key":"2023071714005159100_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1182\/blood.V126.23.681.681","article-title":"Durable remissions in children with relapsed\/refractory ALL treated with T cells engineered with a CD19-targeted chimeric antigen receptor (CTL019)","volume":"126","author":"Grupp","year":"2015","journal-title":"Blood"},{"key":"2023071714005159100_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41408-018-0117-0","article-title":"Survival after blinatumomab treatment in pediatric patients with relapsed\/refractory B-cell precursor acute lymphoblastic leukemia","volume":"8","author":"Gore","year":"2018","journal-title":"Blood Cancer J"},{"key":"2023071714005159100_bib7","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1158\/0008-5472.CAN-18-3800","article-title":"IL-12 abrogates calcineurin-dependent immune evasion during leukemia progression","volume":"79","author":"Rabe","year":"2019","journal-title":"Cancer Res"},{"key":"2023071714005159100_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2023071714005159100_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.dci.2018.05.008","article-title":"Siglecs: a journey through the evolution of sialic acid-binding immunoglobulin-type lectins","volume":"86","author":"Bornh\u00f6fft","year":"2018","journal-title":"Dev Comp Immunol"},{"key":"2023071714005159100_bib10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/glycob\/cwm049","article-title":"Siglec-15: an immune system Siglec conserved throughout vertebrate evolution","volume":"17","author":"Angata","year":"2007","journal-title":"Glycobiology"},{"key":"2023071714005159100_bib11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41591-019-0374-x","article-title":"Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy","volume":"25","author":"Wang","year":"2019","journal-title":"Nat Med"},{"key":"2023071714005159100_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2011.05.015","article-title":"Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation","volume":"409","author":"Hiruma","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"2023071714005159100_bib13","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1002\/jbmr.1989","article-title":"Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase\/Akt and Erk pathways in association with signaling adaptor DAP12","volume":"28","author":"Kameda","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2023071714005159100_bib14","doi-asserted-by":"crossref","first-page":"17493","DOI":"10.1074\/jbc.M111.324194","article-title":"Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12 kDa (DAP12)","volume":"287","author":"Ishida-Kitagawa","year":"2012","journal-title":"J Biol Chem"},{"key":"2023071714005159100_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2012.11.036","article-title":"Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice","volume":"53","author":"Hiruma","year":"2013","journal-title":"Bone"},{"key":"2023071714005159100_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/glycob\/cws139","article-title":"The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-beta secretion from monocytes\/macrophages through the DAP12-Syk pathway","volume":"23","author":"Takamiya","year":"2013","journal-title":"Glycobiology"},{"key":"2023071714005159100_bib17","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1111\/cas.14611","article-title":"LINC00973 is involved in cancer immune suppression through positive regulation of Siglec-15 in clear-cell renal cell carcinoma","volume":"111","author":"Liu","year":"2020","journal-title":"Cancer Sci"},{"key":"2023071714005159100_bib18","doi-asserted-by":"crossref","first-page":"710689","DOI":"10.3389\/fonc.2021.710689","article-title":"Siglec-15 promotes tumor progression in osteosarcoma via DUSP1\/MAPK pathway","volume":"11","author":"Fan","year":"2021","journal-title":"Front Oncol"},{"key":"2023071714005159100_bib19","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1073\/pnas.0602030103","article-title":"Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia","volume":"103","author":"Williams","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023071714005159100_bib20","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1101\/gad.1588607","article-title":"Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia","volume":"21","author":"Williams","year":"2007","journal-title":"Genes Dev"},{"key":"2023071714005159100_bib21","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1182\/blood-2010-08-301267","article-title":"Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"117","author":"Boulos","year":"2011","journal-title":"Blood"},{"key":"2023071714005159100_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nbt.4195","article-title":"Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo","volume":"36","author":"Rafiq","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2023071714005159100_bib23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"2023071714005159100_bib24","doi-asserted-by":"crossref","first-page":"11870","DOI":"10.1038\/s41598-022-16152-z","article-title":"B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12","volume":"12","author":"Hunter","year":"2022","journal-title":"Sci Rep"},{"key":"2023071714005159100_bib25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/bjh.17496","article-title":"Sialic acid-binding immunoglobulin-like lectin (Sigelac)-15 is a rapidly internalised cell-surface antigen expressed by acute myeloid leukaemia cells","volume":"193","author":"Cao","year":"2021","journal-title":"Br J Haematol"},{"key":"2023071714005159100_bib26","article-title":"Anti-Siglec15 antibodies and uses thereof","author":"Elvin","year":"2015"},{"key":"2023071714005159100_bib27","doi-asserted-by":"crossref","first-page":"35445","DOI":"10.18632\/oncotarget.16367","article-title":"Pathogenesis of ETV6\/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"2023071714005159100_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/cells9010215","article-title":"ETV6\/RUNX1 fusion gene abrogation decreases the oncogenicity of tumour cells in a preclinical model of acute lymphoblastic leukaemia","volume":"9","author":"Monta\u00f1o","year":"2020","journal-title":"Cells"},{"key":"2023071714005159100_bib29","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2014-01-547943","article-title":"IKK-dependent activation of NF-\u03baB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1","volume":"123","author":"Hsieh","year":"2014","journal-title":"Blood"},{"key":"2023071714005159100_bib30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/glycob\/cwu067","article-title":"The interplay between Siglecs and sialylated pathogens","volume":"24","author":"Chang","year":"2014","journal-title":"Glycobiology"},{"key":"2023071714005159100_bib31","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1242\/jcs.01497","article-title":"Mammalian GRIP domain proteins differ in their membrane binding properties and are recruited to distinct domains of the TGN","volume":"117","author":"Derby","year":"2004","journal-title":"J Cell Sci"},{"key":"2023071714005159100_bib32","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.jaci.2018.10.066","article-title":"Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: receptor expression and targeting using chimeric antibodies","volume":"143","author":"Legrand","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2023071714005159100_bib33","doi-asserted-by":"crossref","first-page":"19645","DOI":"10.1074\/jbc.RA118.005676","article-title":"Soluble Siglec-14 glycan-recognition protein is generated by alternative splicing and suppresses myeloid inflammatory responses","volume":"293","author":"Huang","year":"2018","journal-title":"J Biol Chem"},{"key":"2023071714005159100_bib34","doi-asserted-by":"crossref","first-page":"19189","DOI":"10.1038\/s41598-020-76206-y","article-title":"Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis","volume":"10","author":"Isidro-Hern\u00e1ndez","year":"2020","journal-title":"Sci Rep"},{"key":"2023071714005159100_bib35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/pbc.22941","article-title":"Increased CCL2 and IL-8 in the bone marrow microenvironment in acute lymphoblastic leukemia","volume":"56","author":"de Vasconcellos","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"2023071714005159100_bib36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature24633","article-title":"Origin and differentiation of human memory CD8 T cells after vaccination","volume":"552","author":"Akondy","year":"2017","journal-title":"Nature"},{"key":"2023071714005159100_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cellimm.2008.06.002","article-title":"Leukemia inhibitory factor: role in human mesenchymal stem cells mediated immunosuppression","volume":"253","author":"Nasef","year":"2008","journal-title":"Cell Immunol"},{"key":"2023071714005159100_bib38","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2011-12-396101","article-title":"IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity","volume":"119","author":"Tran","year":"2012","journal-title":"Blood"},{"key":"2023071714005159100_bib39","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1038\/s41467-021-26407-4","article-title":"Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy","volume":"12","author":"Bent","year":"2021","journal-title":"Nat Commun"},{"key":"2023071714005159100_bib40","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.stemcr.2015.04.012","article-title":"Identification of the common origins of osteoclasts, macrophages, and dendritic cells in human hematopoiesis","volume":"4","author":"Xiao","year":"2015","journal-title":"Stem Cell Reports"},{"key":"2023071714005159100_bib41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-065X.2008.00720.x","article-title":"DAP10- and DAP12-associated receptors in innate immunity","volume":"227","author":"Lanier","year":"2009","journal-title":"Immunol Rev"},{"key":"2023071714005159100_bib42","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1021\/acs.jproteome.7b00625","article-title":"Identification of siglec ligands using a proximity labeling method","volume":"16","author":"Chang","year":"2017","journal-title":"J Proteome Res"},{"key":"2023071714005159100_bib43","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1074\/jbc.M113.494542","article-title":"Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption","volume":"289","author":"Stuible","year":"2014","journal-title":"J Biol Chem"},{"key":"2023071714005159100_bib44","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.1158\/0008-5472.CAN-11-1715","article-title":"IKK\u03b2 and NF-\u03baB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1","volume":"71","author":"Sommermann","year":"2011","journal-title":"Cancer Res"},{"key":"2023071714005159100_bib45","doi-asserted-by":"crossref","first-page":"40418","DOI":"10.1038\/srep40418","article-title":"NF-\u03baB activation is critical for bacterial lipoprotein tolerance-enhanced bactericidal activity in macrophages during microbial infection","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"2023071714005159100_bib46","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fimmu.2016.00666","article-title":"Pro-inflammatory-related loss of CXCL12 niche promotes acute lymphoblastic leukemic progression at the expense of normal lymphopoiesis","volume":"7","author":"Balandr\u00e1n","year":"2017","journal-title":"Front Immunol"},{"key":"2023071714005159100_bib47","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/2326-6066.CIR-14-0226","article-title":"Induced PD-L1 expression mediates acquired resistance to agonistic anti-CD40 treatment","volume":"3","author":"Zippelius","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"2023071714005159100_bib48","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1083\/jcb.67.3.835","article-title":"Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma","volume":"67","author":"Blobel","year":"1975","journal-title":"J Cell Biol"},{"key":"2023071714005159100_bib49","doi-asserted-by":"crossref","first-page":"44043","DOI":"10.1038\/srep44043","article-title":"Secreted ectodomain of SIGLEC-9 and MCP-1 synergistically improve acute liver failure in rats by altering macrophage polarity","volume":"7","author":"Ito","year":"2017","journal-title":"Sci Rep"},{"key":"2023071714005159100_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.placenta.2016.10.013","article-title":"Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta","volume":"48","author":"Ye","year":"2016","journal-title":"Placenta"},{"key":"2023071714005159100_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gene.2009.06.013","article-title":"Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand","volume":"446","author":"Balkan","year":"2009","journal-title":"Gene"},{"key":"2023071714005159100_bib52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.20071641","article-title":"Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates","volume":"205","author":"Sarkar","year":"2008","journal-title":"J Exp Med"},{"key":"2023071714005159100_bib53","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","article-title":"Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group","volume":"28","author":"Haferlach","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-23-0056\/3342280\/crc-23-0056.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/7\/1248\/3347944\/crc-23-0056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/7\/1248\/3347944\/crc-23-0056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T10:02:09Z","timestamp":1689588129000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/3\/7\/1248\/727808\/Siglec-15-Promotes-Evasion-of-Adaptive-Immunity-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,17]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0056","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.23695951.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695939.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695939","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695954.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695942","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695957.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695954","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695966","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6710729.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695957","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695969","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695945","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695942.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695936.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6710729.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695945.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695948.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695963.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695936","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695966.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695960","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695972","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695960.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695975.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695969.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695972.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695948","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695975","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695951","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695963","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6710729","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.23695960.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695969","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695945","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695948.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695957","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695942.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695945.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695954","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695966","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695942","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695954.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695939","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695951.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695957.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695939.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695936.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695963","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695975","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695951","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695936","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695948","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695975.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695966.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695972.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695963.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695969.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695972","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.23695960","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]}}}